BCDA (BioCardia) Insider Ownership: 75.65 % (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BCDA BioCardia Inc BCDA
25 GF Score
Price $0.95
! 1 Warning Sign
View Full Analysis

What is BioCardia Insider Ownership?

BioCardia BCDA +2.15% 25 Insider Ownership is 75.65 % as of Aug. 06, 2026. GuruFocus rates BCDA with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioCardia's insider ownership is 75.65%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioCardia's Institutional Ownership is 4.78%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioCardia's Float Percentage Of Total Shares Outstanding is 87.49%.

BioCardia Insider Ownership Historical Data

* Premium members only.

The historical data trend for BioCardia's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCardia Insider Ownership Chart

BioCardia Historical Data

The historical data trend for BioCardia can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Insider Ownership 93.45 93.49 93.49 93.49 85.58 85.58 85.58 78.42 78.42 75.65
BCDA
25GF Score
BioCardia Inc BCDA
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioCardia Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 75.65 % mean?
BioCardia (BCDA) has a Insider Ownership of 75.65 % as of Aug. 06, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on BioCardia and its competitors.
Is BioCardia's Insider Ownership too high?
BioCardia's current Insider Ownership is 75.65 %. Overall, BioCardia has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does BioCardia's Insider Ownership compare to SNTI and COCP?
BioCardia's Insider Ownership of 75.65 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on BioCardia and its competitors. BioCardia's current Insider Ownership is 75.65 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioCardia stock overvalued right now?
BioCardia (BCDA) has a current Insider Ownership of 75.65 %. The current Insider Ownership is 75.65 %. BioCardia's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For BioCardia (BCDA), the current Insider Ownership is 75.65 % as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioCardia Business Description

Address 320 Soquel Way, Sunnyvale, CA, USA, 94085
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
25GF Score

Get the complete analysis for BCDA

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price